Candida auris as an emerging threat in intensive care units: A single-center retrospective study

Bülent Kaya1, Serap Demir Tekol2, Elif Bombacı3

  • 1Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Kartal Dr Lütfi Kırdar City Hospital, Istanbul, Türkiye.

IJID Regions
|March 27, 2026
PubMed
Abstract

Insights

Candida auris bloodstream infections are a growing threat in intensive care units. This study found high fluconazole resistance and echinocandin susceptibility, emphasizing the need for better surveillance and diagnostics.

Area of Science:

  • Infectious Diseases
  • Mycology
  • Critical Care Medicine

Background:

  • Candida auris is an emerging multidrug-resistant fungal pathogen causing healthcare-associated outbreaks globally.
  • It is increasingly recognized as a significant cause of invasive bloodstream infections, particularly in intensive care settings.

Purpose of the Study:

  • To analyze the characteristics, antifungal susceptibility, and outcomes of Candida auris bloodstream infections in a tertiary care hospital.
  • To evaluate the effectiveness of implemented infection control measures and identify challenges in managing C. auris.

Main Methods:

  • Retrospective single-center study of 31 patients with C. auris blood cultures from December 2021 to December 2024.
  • Evaluation of demographic data, comorbidities, antifungal susceptibility profiles, treatment strategies, and in-hospital outcomes.
  • Utilized hospital information system records for data extraction.

Main Results:

  • A high prevalence of fluconazole resistance (60%) was observed in C. auris isolates.
  • All isolates remained susceptible to echinocandins (caspofungin, micafungin), which were used as first-line therapy.
  • Delayed detection and limited access to reference susceptibility testing posed significant challenges.

Conclusions:

  • Strengthened active surveillance, rapid diagnostics, and standardized susceptibility testing are crucial for controlling nosocomial transmission of C. auris.
  • Enhanced infection control measures, including isolation and environmental decontamination, are necessary.
  • Improving diagnostic capacity is vital for better clinical outcomes in high-risk intensive care settings.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.6K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.4K